Bill Summary for H 524 (2021-2022)

Summary date: 

Apr 9 2021

Bill Information:

View NCGA Bill Details2021
House Bill 524 (Public) Filed Thursday, April 8, 2021
AN ACT TO REQUIRE COVERAGE FOR ORALLY ADMINISTERED ANTICANCER DRUGS DURING COVID-19 STATE OF EMERGENCY.
Intro. by Cunningham, Adcock, Sasser.

View: All Summaries for BillTracking:

Bill summary

Includes whereas clauses. 

Sets out the following requirements for every health benefit plan offered in this State that provides coverage for prescribed, orally administered anticancer drugs that are used to kill or slow the growth of cancerous cells and that provides coverage for intravenously administered or injected anticancer drugs: (1) requires the health benefit plan to cover prescribed, orally administered anticancer drugs on a basis that is no less favorable than the plan's coverage for intravenously administered or injected anticancer drugs; and (2) specifies that coverage for orally administered anticancer drugs is not subject to any prior authorization, dollar limit, copayment, coinsurance, or deductible provision or to any other out-of-pocket expense that does not apply to intravenously administered or injected anticancer drugs. Gives the Commissioner of Insurance enforcement authority and allows for the adoption of temporary rules. Prohibits an insurer from complying with this act by increasing expenses imposed on anticancer drugs. Requires any health benefit plan change increasing an out-of-pocket expense applied to anticancer drugs to also be applied to the majority of comparable medical or pharmaceutical benefits covered by that health benefit plan. Expires 60 days after the date Executive Order No. 116, Declaration of a State of Emergency to Coordinate Response and Protective Actions to Prevent the Spread of COVID-19, expires or is rescinded.

© 2021 School of Government The University of North Carolina at Chapel Hill

This work is copyrighted and subject to "fair use" as permitted by federal copyright law. No portion of this publication may be reproduced or transmitted in any form or by any means without the express written permission of the publisher. Distribution by third parties is prohibited. Prohibited distribution includes, but is not limited to, posting, e-mailing, faxing, archiving in a public database, installing on intranets or servers, and redistributing via a computer network or in printed form. Unauthorized use or reproduction may result in legal action against the unauthorized user.

Printer-friendly: Click to view